Restrict use of pain reliever Tapentadol: Child rights panel urges government

“The chairperson, NCPCR recommended to examine the issue to notify the drug under Schedule H 1 of Drugs and Cosmetics Rules, 1945,” another official said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/334iaag
via IFTTT

0 comments:

Post a Comment